-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Veracyte, Raises Price Target to $57

Benzinga·06/01/2026 15:22:34
Listen to the news
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $48 to $57.